Neurosciences articles for Canada

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 140

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.03
Lipid nanoparticles hijack neutrophils for enhanced anti-inflammatory and stroke therapy 0.03
1 1.00
Migraine, comorbidity, and risks of severe maternal and neonatal morbidity or mortality: a population-based cohort study 1.00
1 0.47
Landscapes of missense variant impact for human superoxide dismutase 1 0.47
1 1.00
Distinct Role of Dural and Leptomeningeal Macrophages in Maintaining Cerebrospinal Fluid Drainage to Meningeal Lymphatic Vessels 1.00
1 1.00
Magneto‐Luminescence Thermometry with Magnetic Circularly Polarized Luminescence 1.00
1 0.95
Multiple Health Care Encounters Prior to Diagnosis of Cerebral Venous Thrombosis 0.95
1 0.11
Action Collaborative on Traumatic Brain Injury Care: Adapted Clinical Practice Guideline 0.11
16 4.48
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment 0.08
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.09
Conditioning Electrical Stimulation for Patients with Moderate or Severe Carpal Tunnel Syndrome: Double Blinded Randomized Controlled Trial 0.83
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.06
Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral Hemorrhage 0.06
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.12
Additive Effects of White Matter Hyperintensity and APOE ε4 Status on Risk of Incident Dementia in Two Large Longitudinal Cohorts 0.06
Real‐World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease‐Modifying Therapy in Pediatric Multiple Sclerosis 0.04
Detecting Awareness in the Intensive Care Unit Using Functional Near‐Infrared Spectroscopy 0.95
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.02
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis 0.18
Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis 0.14
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study 0.30
TARDBP (TDP-43) Knock-in Zebrafish Display a Late-Onset Motor Phenotype and Loss of Large Spinal Cord Motor Neurons 1.00
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline 0.50
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis 0.04
3 0.54
A Non-Inferiority Randomized Clinical Trial Comparing Three Delivery Formats of a Rehabilitation Intervention to Reduce Fatigue among People with Multiple Sclerosis 0.21
New Diagnostic Criteria for Mild Traumatic Brain Injury: Medical-Legal Considerations 0.20
Dysphagia Screening in Acute Stroke: Adaptation and Validation of Modified Volume Viscosity Swallowing Test with International Dysphagia Diet Standardisation Initiative Standards 0.13
16 5.60
Clinical-biological Alzheimer’s disease stage concordance: insights from cohorts and autopsy data 0.79
Enhanced mGluR1 function causes motor deficits and region-specific Purkinje cell dysfunction 0.05
Vaccines mimicking conformational epitopes on α-synuclein fibrils provide immunity to Parkinson’s disease 0.45
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry 0.08
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 0.08
Targeting lipid droplets in FUS-linked amyotrophic lateral sclerosis mitigates neuronal and astrocytic lipotoxicity 0.80
Skin intraneural phosphorylated α-synuclein is a highly specific biomarker for early Parkinson’s disease 0.12
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.26
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.05
Traumatic brain injury or head impacts from contact sports are associated with tau astrogliopathy 0.10
Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy 0.88
Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder 0.64
CSF proteomics of semorinemab Alzheimer’s disease trials identifies cell-type specific signatures 0.08
Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan 0.18
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing 1.00
Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke 0.03
1 0.04
Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling 0.04
1 0.06
Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring. 0.06
1 0.60
Functional organization of voice patches in marmosets and cross-species comparisons with macaques and humans 0.60
1 0.79
Exposure to low-dose ionizing radiation and dementia mortality in Canadian nuclear power plant workers 0.79
1 0.02
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.02
2 0.22
Subjective and Functional Dysphagia After Anterior Cervical Spine Surgery: A Prospective Controlled Study. 0.09
Spinal Fusion in Patients with GMFCS IV or V Cerebral Palsy: Durable Correction and Lasting Quality of Life Improvements: Five-Year Multicenter Outcomes. 0.13
4 1.07
Pathogenic variants in BORCS5 Cause a Spectrum of Neurodevelopmental and Neurodegenerative Disorders with Lysosomal Dysfunction 0.15
Mouse model of atypical DAT deficiency syndrome uncovers dopamine dysfunction associated with parkinsonism and ADHD 0.09
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy 0.05
4E-BP1–dependent translation in microglia controls mechanical hypersensitivity in male and female mice 0.77
2 1.65
Dynamic alterations of dural and bone marrow B cells in an animal model of progressive multiple sclerosis 0.78
A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain 0.88
5 4.87
Frequency-dependent Inhibition during Deep Brain Stimulation of Thalamic Ventral Intermediate Nuclei 1.00
Hemodynamic and Electrophysiological Progression of the Rose Bengal Photothrombotic Stroke Model in Mice 0.89
Spinal processing of spatiotemporally diverse tactile stimuli: Computational insights into allodynia and spinal cord stimulation 1.00
Marmoset Anterior Cingulate Area 32 Neurons Exhibit Responses to Presented and Produced Calls during Naturalistic Vocal Communication 1.00
Multivariate White Matter Microstructure Alterations in Older Adults with Coronary Artery Disease 0.98
2 1.36
Ventilatory and cerebrovascular responses to exercise in lowlander children acclimatizing to high‐altitude 0.58
Acute intermittent hypercapnic hypoxia augments left ventricular contractility 0.78
3 0.39
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum 0.17
Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study 0.12
Reduced glymphatic clearance in early psychosis 0.10
2 0.21
A parabrachial hub for need-state control of enduring pain 0.09
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction 0.13
1 1.00
Glucosylceramide-induced ectosomes propagate pathogenic α-synuclein in Parkinson’s disease 1.00
17 6.71
Blood flow patterns in mice are regulated by interpericyte tunneling nanotubes connecting functionally-opposite neuronal areas 0.22
Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions 0.97
4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy 0.87
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsy 0.84
Status dystonicus is a distinct state characterized by pallidal beta-band activity 0.96
Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency 0.23
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoids 0.02
Astrocytes modulate neuronal development by S100A6 signaling 0.07
Estrogen-related receptor gene expression associates with sex differences in cortical atrophy in isolated REM sleep behavior disorder 0.30
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease 0.02
CSF total tau as a proxy of synaptic degeneration 0.04
Regional heterogeneity of the blood-brain barrier 0.17
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease 0.21
Microglial cyclooxygenase-1 modulates cerebral capillary basal tone in vivo in mice 0.15
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease 0.17
Pharmacological and physiological activation of TGR5 in the NTS lowers food intake by enhancing leptin-STAT3 signaling 0.67
Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain 0.81
3 1.09
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.07
Single-cell expression QTL analyses of the human cerebellum reveal vulnerability of oligodendrocytes in essential tremor 1.00
Base editing of trinucleotide repeats that cause Huntington’s disease and Friedreich’s ataxia reduces somatic repeat expansions in patient cells and in mice 0.02
1 0.08
Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases 0.08
7 0.32
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial 0.03
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial 0.07
Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial 0.06
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.06
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis 0.04
Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial 0.02
AI-driven reclassification of multiple sclerosis progression 0.05
7 2.26
Adversarial AI reveals mechanisms and treatments for disorders of consciousness 0.03
Organization of neuropeptide systems in the human brain 1.00
Sleep-dependent infraslow rhythms are evolutionarily conserved across reptiles and mammals 0.05
Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling 0.75
Subsecond dopamine fluctuations do not specify the vigor of ongoing actions 0.17
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease 0.22
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.05
6 3.02
Basolateral amygdala astrocytes encode anxiety states 1.00
Stochastic misfolding drives the emergence of distinct α-synuclein strains 0.73
Hippocampal estrogen levels, receptor types, and epigenetics contribute to sex-specific memory vulnerabilities to concurrent acute stresses 0.17
The brain neurovascular epigenome and its association with dementia 0.02
Microglia regulate neuronal activity via structural remodeling of astrocytes 0.94
In vivo 7 Tesla MRI of non-human primate intracortical microvascular architecture 0.17
2 1.80
Five energy metabolism pathways show distinct regional distributions and lifespan trajectories in the human brain 0.80
Mapping cerebral blood perfusion and its links to multi-scale brain organization across the human lifespan 1.00
1 0.07
Two pairs of CACNA1I (CaV3.3) variants with opposite effects on channel function cause neurodevelopmental disorders of varying severity 0.07
1 0.06
Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson’s disease: A Chinese retrospective multicenter cohort study 0.06
6 3.50
High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin 0.78
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study 0.53
SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study 0.50
Characterization of endothelin-converting enzyme 1 as a key enzyme in the multienzyme Aβ degradation pathway 0.95
Keratinocyte–TRPV1 sensory neuron interactions in a genetically controllable mouse model of chronic neuropathic itch 0.08
Imaging a concussion and the ensuing immune response at the blood–brain barrier 0.67
1 0.06
Net Water Uptake at CT Predicts the Treatment Effect of Thrombectomy for Low ASPECTS Stroke. 0.06
12 5.78
Broad presence of ferromagnetism in bees and relationship to phylogeny, natural history, and sociality 0.10
Regulation of autism-related self-injurious behavior by electrical stimulation of corticostriatal circuits in mice and humans 0.98
Tubulin polymerization dynamics are influenced by magnetic isotope effects consistent with the radical pair mechanism 0.80
GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice 0.58
Identification and characterization of botulinum neurotoxin–like two-component toxins in Paeniclostridium ghonii 0.22
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology 0.25
Brain stimulation preferentially influences long-range projections 1.00
Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits 0.10
A robust expression system reveals distinct gating mechanisms and calmodulin regulation of NaV1.9 channels 0.50
Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity 0.86
Optimal focused ultrasound lesion location in essential tremor 0.29
Biomimetic elasticity compressed assembly controls rapid intracerebral drug release to reverse microglial dysfunction 0.11
4 0.34
Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletes 0.08
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis 0.06
Brain-derived tau for monitoring brain injury in acute ischemic stroke 0.17
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21–FOXO1 axis in pathogenic T helper 17 cells 0.03
1 0.04
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial 0.04
1 0.60
The burden of stroke, ischaemic heart disease, and dementia in Africa, 1990–2021: an ecological analysis of the Global Burden of Disease 2021 0.60
2 0.27
Asundexian for Secondary Stroke Prevention 0.17
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus 0.10

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.